Catalyst
Slingshot members are tracking this event:
Alkermes (ALKS) Phase 1 Study Testing ALKS-4230, on Solid Tumors Expected late 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ALKS |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 08, 2017
Occurred Source:
http://phx.corporate-ir.net/phoenix.zhtml?c=92211&p=irol-corporateNewsArticle&ID=2315292
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Tumors, Phase 1 Study, Multiple Sclerosis Disease, Multiple Solid Tumors, Alks 8700
